0.00Open0.01Pre Close0 Volume15 Open Interest100.00Strike Price0.00Turnover90.37%IV24.64%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0048Delta0.0021Gamma8024.00Leverage Ratio-0.0088Theta0.0000Rho38.88Eff Leverage0.0010Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet